DIM-Avail 100mg: Clinical Trials

1 completed. 1 Not applicable.

By phase and status

Phase	Trials	Status
Not applicable	1	Completed 1

Follow DIM-Avail 100mg: new trials by email Literature Review of DIM-Avail 100mg trials Research Report on DIM-Avail 100mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Nutritional Intervention to Decrease Breast Density Among Female BRCA (BReast CAncer Susceptibility Gene) Carriers DIM-Avail 100mg - BRCA1 Gene Mutation, BRCA2 Gene Mutation	Not applicable	Completed	Rabin Medical Center	23	2014-11-11	2020-11-12

Conditions studied

Breast Neoplasms (1)

Sponsors

Rabin Medical Center (1)

Countries

Israel (1)

Top investigators

David Margel, MD, PhD (1)  ·  Rinat Yerushalmi, MD (1)